Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Essential role for ADAM19 in cardiovascular morphogenesis.

Hong-Ming Zhou1, Gisela Weskamp, Valérie Chesneau

  • 1Cell Biology Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

Molecular and Cellular Biology
|December 16, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.

Science advances·2026
Same author

Structural basis for ADAM17 activation by the iRhom1 pseudoprotease.

Cell reports·2026
Same author

Trps1 enhances Hdac4 and Gli3 protein stability and nuclear localization independent of PKA and PP2A signaling.

Cellular signalling·2025
Same author

Paired plus-minus sequencing is an ultra-high throughput and accurate method for dual strand sequencing of DNA molecules.

bioRxiv : the preprint server for biology·2025
Same author

Human Single-Nucleus RNA Sequencing Identifies CD47 as a Therapeutic Target for Doxorubicin-Induced Cardiomyopathy.

Circulation·2025
Same author

Melanoma microsatellites exhibit a metastatic signature by spatial transcriptomics and overexpress mediators of immune evasion.

Virchows Archiv : an international journal of pathology·2025

Mice lacking ADAM19 (a disintegrin and metalloprotease 19) showed severe congenital heart defects, including septal and valve abnormalities. This suggests ADAM19 mutations may cause human heart defects.

Area of Science:

  • Developmental Biology
  • Genetics
  • Cardiovascular Research

Background:

  • Congenital heart disease (CHD) is a prevalent birth defect with largely unknown causes.
  • Understanding the genetic basis of cardiac development is crucial for addressing CHD.

Purpose of the Study:

  • To investigate the role of ADAM19 (a disintegrin and metalloprotease 19) in cardiac morphogenesis.
  • To determine if ADAM19 deficiency leads to congenital heart defects in a mouse model.

Main Methods:

  • Generation and analysis of ADAM19-deficient mice (adam19-/-).
  • Detailed examination of cardiac structures and vasculature during embryonic development.
  • Assessment of ADAM19 expression patterns in developing tissues.

Main Results:

Related Experiment Videos

  • ADAM19-deficient mice exhibited severe cardiac defects, including ventricular septal defects (VSDs).
  • Abnormalities in aortic and pulmonic valve formation, leading to stenosis, were observed.
  • Cardiac vasculature development was also impaired in these mice.
  • ADAM19 expression was prominent in key cardiac developmental structures like the conotruncus and endocardial cushions.

Conclusions:

  • ADAM19 is essential for normal cardiac morphogenesis, particularly for septal and valve formation.
  • ADAM19 deficiency in mice results in severe, often lethal, congenital heart defects.
  • Mutations in ADAM19 represent a potential genetic cause for human congenital heart valve and septal defects.